I​an Hermans
Chief Science Officer
Cancer
Avaliaimmuno Therapies
New Zealand
Biography
D​r Hermans is one of two founding scientists whose research career in the field of T cell immunology has set the development agenda for Avalia Immunotherapies. In addition to his role with Avalia, Associate Professor Hermans is Deputy Director of Research at the Malaghan Institute, overseeing the institute's involvement in cancer vaccine development. In 2001, he held a position at the Tumour Immunology Unit, Weatherall Institute of Molecular Medicine, at the University of Oxford, UK. In 2005 Dr Hermans was awarded a Sir Charles Hercus Research Fellowship from the Health Research Council of New Zealand to pursue his research into improving the potency and efficacy of vaccines by exploiting the activity of NKT cells. Dr Hermans has authored over 60 peer reviewed publications and is a named inventor on several patents.
Research Interest
Cancer